GJA1 reverses arsenic-induced EMT via modulating MAPK/ERK signaling pathway.
Wu L, Wang Z, He X, Jiang Y, Pan R, Chen S, Chen Y, Han Y, Yu H, Zhang T.
Wu L, et al. Among authors: yu h.
Toxicol Appl Pharmacol. 2022 Sep 1;450:116138. doi: 10.1016/j.taap.2022.116138. Epub 2022 Jun 21.
Toxicol Appl Pharmacol. 2022.
PMID: 35750204
Free article.